Access Pharmaceuticals (ACCP) Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
7/27/2009 9:05:01 AM
More...
|
Access Pharmaceuticals (ACCP) Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
6/30/2009 8:25:36 AM
More...
|
Access Pharmaceuticals (ACCP) Announces the European Launch of MuGard(TM) by its European Partner, SpePharm
4/22/2009 8:50:33 AM
More...
|
SpePharm Announces the European Launches of Two New Products: MuGard(R) and Xerotin(R)
4/20/2009 10:08:12 AM
More...
|
SpePharm Announces a Claim in Excess of 35 Million Euros Against BioAlliance Pharma For Breaking up Their Joint-Venture
4/14/2009 6:57:48 AM
More...
|
SpePharm Initiates Legal Actions Against BioAlliance Pharma for Breaking Up Joint-Venture SpeBio
3/3/2009 10:44:49 AM
More...
|
JHP Pharmaceuticals and SpePharm Complete Purchase of Dantrium
8/21/2008 2:00:32 PM
More...
|
TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into €26 Million Financing of SpePharm
8/21/2008 12:12:15 PM
More...
|
JHP Pharmaceuticals and SpePharm Complete Purchase of Dantrium(R)
8/20/2008 8:32:52 AM
More...
|
SpePharm Announces the Granting of National Marketing Authorizations for Loramyc(R) in Europe and First Launch in the UK
6/5/2008 9:21:27 AM
More...
|
|